BioLife Solutions develops, manufactures and markets bioproduction tools and services to the cell and gene therapy industry. Co. has five main offerings: biopreservation media, which includes HypoThermosol® FRS and CryoStor® products; automated thawing devices, which include automated vial and cryobag thawing products; cloud connected smart shipping containers, which include evo.is cloud app that allows biologic products to be traced and tracked in real time; freezer and storage technology and related components, which include liquid nitrogen laboratory freezers, cryogenic equipment and accessories; and biological and pharmaceutical material storage, which provides cold chain logistics. The BLFS stock yearly return is shown above.
The yearly return on the BLFS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BLFS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|